2023-05-25 05:30:00 ET
CRISPR Therapeutics (NASDAQ: CRSP) and Teladoc Health (NYSE: TDOC) both score a win when it comes to innovation in healthcare. CRISPR has developed a gene-editing approach that aims to fix faulty genes responsible for disease. Teladoc leads in telemedicine, allowing patients to visit doctors from the comfort of an armchair at home.
These companies are driving significant positive change in the world of healthcare. Last year, though, this idea didn't boost their shares. CRISPR and Teladoc dropped in the double digits.
These days, the stocks are recovering -- and you may be thinking of hopping onboard. But if you could only buy one of these growth stocks, which one should you choose?
For further details see:
Better Growth Stock: CRISPR Therapeutics vs. Teladoc Health